These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 34732121)
1. Anti-proliferative, c-Met Inhibitions, and PAINS Evaluations of New Thiophene, Thiazole, Coumarin, Pyran, and Pyridine Derivatives. Mohareb RM; Abdo NYM; Ibrahim RA; Samir EM Anticancer Agents Med Chem; 2022; 22(11):2125-2141. PubMed ID: 34732121 [TBL] [Abstract][Full Text] [Related]
2. Multi-Component Reactions of Cyclohexan-1,3-dione: Synthesis of Fused Pyran, Pyridine, Thiophene and Pyrazole Derivatives with c-Met, Anti-Proliferative Activities. Mohareb RM; Elmetwally AM; Mohamed AA Anticancer Agents Med Chem; 2021; 21(17):2443-2463. PubMed ID: 33438568 [TBL] [Abstract][Full Text] [Related]
3. New Approaches for the Synthesis of Fused Thiophene, Pyrazole, Pyran and Pyridine Derivatives with Anti-Proliferative Together with c-Met Kinase and Prostate Cancer Cell Inhibitions. Mohareb RM; Milad YR; El-Ansary RA Anticancer Agents Med Chem; 2021; 21(13):1751-1766. PubMed ID: 33176664 [TBL] [Abstract][Full Text] [Related]
4. Heterocyclization of 2-(2-phenylhydrazono)cyclohexane-1,3-dione to Synthesis Thiophene, Pyrazole and 1,2,4-triazine Derivatives with Anti-Tumor and Tyrosine Kinase Inhibitions. Mohareb RM; Alwan ES Anticancer Agents Med Chem; 2020; 20(10):1209-1220. PubMed ID: 32156245 [TBL] [Abstract][Full Text] [Related]
5. Heterocyclization of 2-Arylidenecyclohexan-1,3-dione: Synthesis of Thiophene, Thiazole, and Isoxazole Derivatives with Potential Antitumor Activities. Abdo NYM; Mohareb RM; Al-Darkazali WN Anticancer Agents Med Chem; 2020; 20(3):335-345. PubMed ID: 31362693 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and Anti-Proliferative Evaluations of New Heterocyclic Derivatives Using 5,6,8,9-Tetrahydropyrazolo[5,1-b]quinazolin-7(3H)-one Derivatives Derived from Cyclohexa-1,4-dione. Mahmoud MAA; Alsharif MA; Mohareb RM Anticancer Agents Med Chem; 2021; 21(4):468-486. PubMed ID: 32445457 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of Tetrahydrobenzo[ Mohareb RM; Wardakhan WW; Abbas NS Anticancer Agents Med Chem; 2019; 19(14):1737-1753. PubMed ID: 30947678 [TBL] [Abstract][Full Text] [Related]
8. New Approaches for the Synthesis of 2,3,5,6-Tetrahydrobenzo[d]thiazole Derivatives and their Anti-Proliferative, c-Met Enzymatic Activity and Tyrosine Kinases Inhibitions. Mohareb RM; Helal MHE; Mohamed SS; Abdallah AEM Anticancer Agents Med Chem; 2022; 22(12):2327-2339. PubMed ID: 34951581 [TBL] [Abstract][Full Text] [Related]
9. New Approaches for the Synthesis of Heterocyclic Compounds Corporating Benzo[d]imidazole as Anticancer Agents, Tyrosine, Pim-1 Kinases Inhibitions and their PAINS Evaluations. Mohareb RM; Milad YR; Mostafa BM; El-Ansary RA Anticancer Agents Med Chem; 2021; 21(3):327-342. PubMed ID: 32698742 [TBL] [Abstract][Full Text] [Related]
10. The Uses of Dimedone for the Synthesis of Thiophene, Thiazole and Annulated Derivatives with Antitumor, Pim-1 Kinase Inhibitions, PAINS Evaluations and Molecular Docking. Wardakhan WW; Elmetwally AM; Mohamed AA; Mohareb RM Anticancer Agents Med Chem; 2021 Oct; 21(16):2258-2277. PubMed ID: 33463476 [TBL] [Abstract][Full Text] [Related]
11. Uses of cyclohexane-1,3-dione for the synthesis of 1,2,4-triazine derivatives as anti-proliferative agents and tyrosine kinases inhibitors. Megally Abdo NY; Milad Mohareb R; Halim PA Bioorg Chem; 2020 Apr; 97():103667. PubMed ID: 32087416 [TBL] [Abstract][Full Text] [Related]
12. New Approaches for the Uses of Cyclohexan-1,4-dione for the Synthesis of 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-b]pyridine Derivatives used as Potential Anti-prostate Cancer Agents and Pim-1 Kinase Inhibitors. Mohareb RM; Abdo NYM; El-Sharkawy KA Anticancer Agents Med Chem; 2018; 18(12):1736-1749. PubMed ID: 29866019 [TBL] [Abstract][Full Text] [Related]
13. Antiproliferative and Antiprostate Cancer Activities of Heterocyclic Compounds Derived from Cyclohexane-1,4-dione. Mohareb RM; Abdo NYM Acta Chim Slov; 2022 Sep; 69(3):700-713. PubMed ID: 36196826 [TBL] [Abstract][Full Text] [Related]
14. New Approaches for the Synthesis N-alkylated Benzo[ El-Sharkawy KA; Mohamed AA; Al Farouk FO; Mohareb RM Anticancer Agents Med Chem; 2023; 23(12):1429-1446. PubMed ID: 36927433 [TBL] [Abstract][Full Text] [Related]
15. Anti-proliferative, Morphological and Molecular Docking Studies of New Thiophene Derivatives and their Strategy in Ionic Liquids Immobilized Reactions. Mohareb RM; Mukhtar S; Parveen H; Abdelaziz MA; Alwan ES Anticancer Agents Med Chem; 2024; 24(9):691-708. PubMed ID: 38321904 [TBL] [Abstract][Full Text] [Related]
16. Multi-component Reactions of Cyclohexan-1,3-diketones to Produce Fused Pyran Derivatives with Antiproliferative Activities and Tyrosine Kinases and Pim-1 Kinase Inhibitions. Mohareb RM; Ibrahim RA; Alwan ES Acta Chim Slov; 2021 Mar; 68(1):51-64. PubMed ID: 34057520 [TBL] [Abstract][Full Text] [Related]
17. Uses of Cyclohexan-1,4-dione for the Synthesis of 2-Amino-4,5-dihydrobenzo[b]thiophen-6(7H)-one Derivatives with Anti-proliferative and Pim-1 Kinase Activities. Mohareb RM; Abbas NS; Ibrahim RA Chem Pharm Bull (Tokyo); 2017; 65(12):1117-1131. PubMed ID: 29199218 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, and anti-proliferative, Pim-1 kinase inhibitors and molecular docking of thiophenes derived from estrone. Mohareb RM; Samir EM; Halim PA Bioorg Chem; 2019 Mar; 83():402-413. PubMed ID: 30415021 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and Biological Evaluation of Novel 4,5,6,7-Tetrahydrobenzo[D]-Thiazol-2- Yl Derivatives Derived from Dimedone with Anti-Tumor, C-Met, Tyrosine Kinase and Pim-1 Inhibitions. Mohareb RM; Abouzied AS; Abbas NS Anticancer Agents Med Chem; 2019; 19(12):1438-1453. PubMed ID: 31038076 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of Novel Heterocyclic Compounds Incorporate 4,5,6,7-Tetrahydrobenzo[b]thiophene Together with Their Cytotoxic Evaluations. Abdallah AEM; Mohareb RM; Khalil EM; Elshamy MAMAE Chem Pharm Bull (Tokyo); 2017; 65(5):469-477. PubMed ID: 28458368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]